ELIQUIS (apixaban)Tablets, 2.5 mg & 5.0 mg

Bristol-Myers Squibb Company

Revision date : 2013-07-03

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 5
Safety risk rating 5
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

2.4% <40%

EC/CAS

209-150-3/557-04-0

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

<5%

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

<5%

EC/CAS

236-675-5/13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

<1% <50%

General Information

Revision date

2013-07-03

Product name

ELIQUIS (apixaban)Tablets, 2.5 mg & 5.0 mg

Product Synonyms

BMS-562247-01 Tablets; BMS 562247-01 Tablets; AG0023 Tablets; DPH-150123

1.2.1 Relevant identified uses

This material is a finished drug product for patient use. The primary indication is thrombosis

Icons in SDS

GHS07 GHS08

Company Information

company name

Bristol-Myers Squibb Company

e-mail address of the competent person responsible for the Safety Data Sheet

MG-GBS-MSDS-Request@bms.com

GHS Information

Signal word

Danger

Section 2

SECTION 2: Hazards identification

Classification and Labelling Common to All Jurisdictions

2.1 Classification of the substance or mixture

Serious Eye Damage/Eye Irritation - Category 2 Carcinogenicity - Category 2 Specific Target Organ Systemic Toxicity (Single Exposure) - Category 3 Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 2 Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1

Hazard statements

Causes serious eye irritation. Suspected of causing cancer. (inhalation). May cause respiratory irritation . Causes damage to organs (blood, central nervous system, cardiovascular system, eyes) through prolonged or repeated exposure. May cause damage to organs (blood, central nervous system, cardiovascular system, eyes) through prolonged or repeated exposure. UN Causes damage to organs (blood, central nervous system, cardiovascular system, eyes) through prolonged or repeated exposure.

Precautionary statements

Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Wear protective gloves/clothing and eye/face protection. Use personal protective equipment as required. Use only outdoors or in a well-ventilated area. Obtain special instructions before use. Classification and Labelling for Specific Jurisdictions USA Do not eat, drink or smoke when using this product. EU Do not eat, drink or smoke when using this product.

Classifications

Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1

Signal word

Danger Warning Danger

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.